文献速递免疫规划

MIP3α-RelMtb鼻内DNA疫苗接种诱导小鼠和猕猴肺部反应性T细胞浸润

MIP3α-RelMtb intranasal DNA vaccination induces reactive T-cell infiltration into the lungs of mice and macaques.
PubMed 文献 · Vaccine · 2025-07-16

研究在小鼠和恒河猴模型中评估鼻内接种MIP3α-RelMtb融合DNA疫苗的免疫原性。结果显示,系列免疫后MipRel疫苗增强肺部T细胞浸润;尽管MipRel组与Rel组全身T细胞反应相似,MipRel组肺和支气管肺泡灌洗液样本中分泌细胞因子的T细胞更富集。作者结论为鼻内接种MIP-3α融合DNA疫苗是诱导呼吸道抗原特异性T细胞免疫反应的新策略。

要点

  • 鼻内接种MipRel DNA疫苗增强小鼠和猕猴肺部T细胞浸润。
  • MipRel组与Rel组全身T细胞反应相似。
  • MipRel组肺和支气管肺泡灌洗液样本中分泌细胞因子的T细胞较Rel组更富集。

核心结论

  • 鼻内免疫简单MIP-3α融合DNA疫苗是诱导呼吸道内抗原特异性T细胞免疫反应的新策略。
  • 该制剂在历来被视为对DNA疫苗反应不佳的非人灵长类模型中具有免疫原性,表明其有潜力用于结核分枝杆菌感染治疗的临床应用,并可能应用于其他呼吸道病原体。

研究设计与样本

  • 研究在小鼠和恒河猴模型中进行免疫原性研究,评估鼻内接种MipRel DNA疫苗。

主要发现

  • 系列免疫后,鼻内接种MipRel DNA疫苗导致肺部T细胞浸润增强。
  • 尽管MipRel组与Rel组全身T细胞反应相似,MipRel组肺和支气管肺泡灌洗液细胞样本中分泌细胞因子的T细胞较Rel组更富集。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is the leading cause of mortality due to a single infectious organism. While generally curable, TB requires a lengthy and complex antibiotic regimen, due in large part to persistent bacteria that survive antibiotic exposure. RelMtb is the primary enzyme regulating the stringent response, which contributes to Mtb persistence. Targeting RelMtb with a vaccine to eliminate persistent bacteria in combination with antibiotics to kill dividing bacteria has shown promise in model systems. In a mouse model of Mtb infection, a vaccine created by genetically fusing relMtb to the chemokine macrophage inflammatory protein 3α (MIP3α), a ligand for the CC chemokine receptor type 6 (CCR6) present on immature dendritic cells, has been shown to enhance T-cell responses and accelerate eradication of infection in mouse models compared to a vaccine lacking the chemokine component. In this study, immunogenicity studies in the mouse and rhesus macaque models provide evidence that intranasal administrations of the DNA form of the MipRel vaccine led to enhanced lung infiltration of T cells after a series of immunizations. Furthermore, despite similar systemic T-cell responses following MipRel or Rel vaccination, lung and bronchoalveolar lavage cell samples were more enriched for cytokine-secreting T cells in MipRel groups compared to Rel groups. We conclude that intranasal immunization with a simple MIP-3α fusion DNA vaccine represents a novel strategy for eliciting T-cell immune responses to antigens of interest within the respiratory tract. That this formulation is immunogenic in a non-human primate model historically viewed as poorly responsive to DNA vaccines indicates the potential for clinical application in the treatment of Mtb infection, with possible applications to other respiratory pathogens.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gordy JT, Zheng JJ, Maxwell AR, et al. MIP3α-RelMtb intranasal DNA vaccination induces reactive T-cell infiltration into the lungs of mice and macaques. Vaccine. 2025. PMID: 40675108. doi:10.1016/j.vaccine.2025.127517

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。